Cargando…

MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with a poor prognosis, and effective treatments for PDAC are lacking. In this study, we hypothesized that miR-506 promotes antitumor immune response in PDAC by reprogramming tumor-associated macrophages toward an M1 phenotype to re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Tiantian, Han, Yitong, Chen, Junhang, Liang, Xiaoyu, Sun, Longhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669181/ https://www.ncbi.nlm.nih.gov/pubmed/38001876 http://dx.doi.org/10.3390/biomedicines11112874

Ejemplares similares

IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer
por: Sun, Longhao, et al.
Publicado: (2022)

The emerging role of miR-506 in cancer
por: Li, Jian, et al.
Publicado: (2016)

Crotoxin promotes macrophage reprogramming towards an antiangiogenic phenotype
por: de Araújo Pimenta, Luciana, et al.
Publicado: (2019)

Phosphatidylcholine Liposomes Reprogram Macrophages toward an Inflammatory Phenotype
por: Cauvi, David M., et al.
Publicado: (2023)

Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
por: Chen, Degao, et al.
Publicado: (2018)

Combination of miR-143 and miR-506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclin-dependent kinases
por: Hossian, A.K.M. Nawshad, et al.
Publicado: (2021)

Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p
por: Vadevoo, Sri Murugan Poongkavithai, et al.
Publicado: (2022)

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
por: Wang, Lin, et al.
Publicado: (2022)

Crosstalk between autophagy and immune cell infiltration in the tumor microenvironment
por: Yang, Tiantian, et al.
Publicado: (2023)

Expression levels of miR-205 and miR-506 in colon cancer tissues and their relationships with clinicopathological features
por: Jing, Nan, et al.
Publicado: (2018)

Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer
por: Krawczyk, Paweł, et al.
Publicado: (2017)

Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Du, Yu, et al.
Publicado: (2022)

Overexpression of MiR-506 in Jurkat (Acute T Cell Leukemia) Cell Line
por: Rostami Yasuj, Shaghayegh, et al.
Publicado: (2020)

Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2021)

Publisher Correction: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
por: Chen, Degao, et al.
Publicado: (2018)

Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression
por: Wang, Liang, et al.
Publicado: (2020)

Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response
por: Wang, Yi-Na, et al.
Publicado: (2023)

miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
por: Arora, Himanshu, et al.
Publicado: (2013)

MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells
por: Yu, Fei, et al.
Publicado: (2015)

miR-506 functions as a tumor suppressor in glioma by targeting STAT3
por: Peng, Tao, et al.
Publicado: (2022)

miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1
por: Chen, Zhiheng, et al.
Publicado: (2015)

MiR-124 and miR-506 are involved in the decline of protein C in children with extra-hepatic portal vein obstruction
por: Zhang, Jin-Shan, et al.
Publicado: (2021)

Crotoxin Modulates Macrophage Phenotypic Reprogramming
por: Neves, Camila Lima, et al.
Publicado: (2023)

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
por: Richert, Iseulys, et al.
Publicado: (2023)

miR-506 inhibits cell proliferation and invasion by targeting TET family in colorectal cancer
por: Wu, Minghao, et al.
Publicado: (2016)

MiR-506 Suppresses Tumor Proliferation and Invasion by Targeting FOXQ1 in Nasopharyngeal Carcinoma
por: Zhang, Zhanchi, et al.
Publicado: (2015)

circPCNX and Pecanex Promote Hepatocellular Carcinoma Cell Viability by Inhibiting miR-506
por: Sun, Peng, et al.
Publicado: (2019)

Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro
por: Hossian, A. K. M. Nawshad, et al.
Publicado: (2018)

Effect of artificial skin membrane on the expression of miR‐155 and miR‐506‐3p in patients with second‐degree burns
por: Li, Fei, et al.
Publicado: (2022)

Antitumor Effect of miR-1294/Pyruvate Kinase M2 Signaling Cascade in Osteosarcoma Cells
por: Yuan, Quan, et al.
Publicado: (2020)

Macrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites Carcinoma
por: Kalish, Sergey V., et al.
Publicado: (2015)

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling
por: Li, J, et al.
Publicado: (2016)

Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
por: Li, Xiang, et al.
Publicado: (2022)

miR‐21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
por: Usuelli, Vera, et al.
Publicado: (2021)

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
por: Yu, Zhuo, et al.
Publicado: (2022)

Vitamin D receptor-deficient keratinocytes-derived exosomal miR-4505 promotes the macrophage polarization towards the M1 phenotype
por: Sun, Wen, et al.
Publicado: (2023)

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
por: Cooks, Tomer, et al.
Publicado: (2018)

49. Recruited Macrophages are Required for Neuroenhancing Effects of Fk506
por: Broberg, Curtis, et al.
Publicado: (2023)

Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines
por: Capone, Francesca, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9ht4e87uf11t2eoeg35503l0mp